Top Markets
Coin of the day
Pharmasimple S.A. Pharmasimple S.A.

Pharmasimple S.A.

ALPHS
Classificação em ações #42853
Pharmasimple SA operates an e-commerce platform offering a wide array of... Pharmasimple SA operates an e-commerce platform offering a wide array of pharmaceuticals, beauty products, and nutritional supplements across Belgium and France. Its extensive catalog includes diverse beauty and cosmetic items such as facial cleansers, skincare treatments, makeup, hair removal solutions, body care, sun protection, and hair care products. The company also provides essential health items, encompassing feminine hygiene, dental care, alternative medicines, hearing aids, and aromatherapy products. A dedicated section caters to men's grooming, featuring face, body, and hair care products, alongside shaving necessities. Furthermore, Pharmasimple offers various dietary aids, sports nutrition, health supplements, and specialized health foods. For infants and children, the selection covers necessities like nappies, baby washes, breastfeeding equipment, baby food, and general baby care items. Completing its offerings are veterinary supplies and pest control products. Pharmasimple SA was established in 2010 and is headquartered in Houdeng-Goegnies, Belgium.
Preço da ação
$0.01394836
Última sincronização: 2023-05-22
Valor de mercado
$0.25
Variação (1 dia)
-0.10%
Variação (1 ano)
0.00%
País
BE
Negociar Pharmasimple S.A. (ALPHS)
Lucros da Pharmasimple S.A. (ALPHS)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Pharmasimple S.A., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Pharmasimple S.A. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$174.93B -
US
$19.15B -
CN
$16.94B -
IE
$2.21B -
UY
$2.37B -
SG